Needham Maintains Buy on Medtronic, Raises Price Target to $114

Benzinga Newsdesk www.benzinga.com Positive 82.0%

Neg 0% Neu 0% Pos 82%

Needham analyst Mike Matson maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $101 to $114.

Comments

No comments yet. Be the first!